{"title":"Oncology","description":"","products":[{"product_id":"abiraterone-acetate-250mg-tablets-abirapro-glenmark","title":"Abiraterone Acetate 250mg Tablets | Abirapro - Glenmark","description":"\u003cp data-path-to-node=\"7\"\u003e\u003cb data-path-to-node=\"7\" data-index-in-node=\"0\"\u003eAdvanced Specialty Oncology Care\u003c\/b\u003e\u003c\/p\u003e\n\u003cp data-path-to-node=\"7\"\u003eWhen addressing specific and complex oncology needs, healthcare providers and patients require treatments that deliver highly precise and reliable results. The \u003cb data-path-to-node=\"7\" data-index-in-node=\"193\"\u003eAbiraterone Acetate Tablets I.P.\u003c\/b\u003e (commercially recognized as Abirapro) provide a potent, targeted oral therapy designed to support critical long-term treatment plans. Manufactured by Glenmark, a globally respected leader in pharmaceutical research and manufacturing, these tablets ensure the steady clinical performance necessary for individuals navigating advanced health challenges.\u003c\/p\u003e\n\u003cp data-path-to-node=\"8\"\u003e\u003cb data-path-to-node=\"8\" data-index-in-node=\"0\"\u003eWhy Choose Abirapro for Clinical Management?\u003c\/b\u003e\u003c\/p\u003e\n\u003cp data-path-to-node=\"8\"\u003eManaging intensive health conditions often requires strict daily protocol adherence. Instead of relying solely on frequent, invasive clinical visits for treatment administration, patients benefit from Abirapro’s formulated oral tablets, which allow for consistent management from home. Glenmark provides the built-in trust, stringent quality control, and proven efficacy that oncologists, specialized clinics, and leading pharmacies demand when stocking life-saving specialty medications.\u003c\/p\u003e\n\u003cp data-path-to-node=\"9\"\u003e\u003cb data-path-to-node=\"9\" data-index-in-node=\"0\"\u003eKey Product Specifications \u0026amp; Clinical Benefits\u003c\/b\u003e\u003c\/p\u003e\n\u003cp data-path-to-node=\"10,0,0\"\u003e\u003cb data-path-to-node=\"10,0,0\" data-index-in-node=\"0\"\u003eTargeted Active Ingredient:\u003c\/b\u003e Contains premium-grade Abiraterone Acetate I.P. (\u003cb data-path-to-node=\"10,0,0\" data-index-in-node=\"77\"\u003e250 mg\u003c\/b\u003e per tablet), a highly effective formulation clinically designed for specific specialty oncology care regimens.\u003c\/p\u003e\n\u003cp data-path-to-node=\"10,1,0\"\u003e\u003cb data-path-to-node=\"10,1,0\" data-index-in-node=\"0\"\u003eOptimized Patient Supply:\u003c\/b\u003e Conveniently packaged in a bulk bottle containing \u003cb data-path-to-node=\"10,1,0\" data-index-in-node=\"76\"\u003e120 tablets\u003c\/b\u003e, ensuring patients have an ample, uninterrupted supply for their ongoing, daily treatment protocols.\u003c\/p\u003e\n\u003cp data-path-to-node=\"10,2,0\"\u003e\u003cb data-path-to-node=\"10,2,0\" data-index-in-node=\"0\"\u003eOral Administration:\u003c\/b\u003e Designed as an easy-to-swallow oral tablet, significantly improving patient compliance and comfort during long-term therapy compared to injectable alternatives.\u003c\/p\u003e\n\u003cp data-path-to-node=\"10,3,0\"\u003e\u003cb data-path-to-node=\"10,3,0\" data-index-in-node=\"0\"\u003eHygienic Packaging:\u003c\/b\u003e The securely sealed bottle protects the sensitive medication from environmental degradation, light, and moisture until the moment of consumption.\u003c\/p\u003e\n\u003cp data-path-to-node=\"11\"\u003e\u003cb data-path-to-node=\"11\" data-index-in-node=\"0\"\u003eEssential Storage \u0026amp; Usage Guidelines\u003c\/b\u003e Protecting the integrity of this specialized medication is vital for its clinical efficacy. Store the tablets in their original container at room temperature, and protect them strictly from light and moisture.\u003c\/p\u003e\n\u003cp data-path-to-node=\"12\"\u003e\u003ci data-path-to-node=\"12\" data-index-in-node=\"0\"\u003e\u003cstrong\u003eImportant Notice:\u003c\/strong\u003e Abirapro is a Schedule H prescription-only medication. It is dangerous to take this preparation except in accordance with medical advice. It must be prescribed, titrated, and strictly monitored by a Registered Medical Practitioner (typically an oncology specialist). Keep securely out of the reach of children.\u003c\/i\u003e\u003c\/p\u003e","brand":"Glenmark","offers":[{"title":"Default Title","offer_id":50187598365029,"sku":null,"price":8400.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0877\/4618\/3525\/files\/ABIRAPRO-250-GLENMARK-Abiraterone-acetate-1.png?v=1772604278"},{"product_id":"bevacizumab-concentrate-for-infusion-bevatas-intas","title":"Bevacizumab Concentrate for Infusion | Bevatas - INTAS","description":"\u003cp data-path-to-node=\"8\"\u003e\u003cb data-path-to-node=\"8\" data-index-in-node=\"0\"\u003eAdvanced Targeted Oncology Care\u003c\/b\u003e\u003c\/p\u003e\n\u003cp data-path-to-node=\"8\"\u003eWhen addressing specific and complex oncology needs, healthcare providers require infusion treatments that deliver highly precise, targeted, and reliable results. The \u003cb data-path-to-node=\"8\" data-index-in-node=\"199\"\u003eBevacizumab Concentrate for Solution for Infusion\u003c\/b\u003e (commercially recognized as Bevatas) provides a potent clinical therapy designed to support critical long-term treatment plans. Manufactured by INTAS Pharmaceuticals, a globally respected leader in medical research and manufacturing, this sterile concentrate ensures the steady clinical performance necessary for patients navigating advanced health challenges.\u003c\/p\u003e\n\u003cp data-path-to-node=\"9\"\u003e\u003cb data-path-to-node=\"9\" data-index-in-node=\"0\"\u003eWhy Choose Bevatas for Clinical Management?\u003c\/b\u003e\u003c\/p\u003e\n\u003cp data-path-to-node=\"9\"\u003eManaging intensive oncology conditions requires strict clinical protocols and highly reliable medication delivery. Instead of utilizing unpredictable formulations, hospitals and clinical infusion centers benefit from Bevatas’s meticulously engineered single-use vials, which guarantee exact dosing and uncompromised sterility. INTAS provides the built-in trust, stringent quality control, and proven efficacy that oncologists, specialized clinics, and leading pharmacies demand when stocking life-saving specialty infusions.\u003c\/p\u003e\n\u003cp data-path-to-node=\"10\"\u003e\u003cb data-path-to-node=\"10\" data-index-in-node=\"0\"\u003eKey Product Specifications \u0026amp; Clinical Benefits\u003c\/b\u003e\u003c\/p\u003e\n\u003cp data-path-to-node=\"11,0,0\"\u003e\u003cb data-path-to-node=\"11,0,0\" data-index-in-node=\"0\"\u003eTargeted Active Ingredient:\u003c\/b\u003e Contains premium-grade Bevacizumab, a specialized formulation clinically designed for advanced oncology care regimens.\u003c\/p\u003e\n\u003cp data-path-to-node=\"11,1,0\"\u003e\u003cb data-path-to-node=\"11,1,0\" data-index-in-node=\"0\"\u003ePrecise Dosing Options:\u003c\/b\u003e Available in two specific strengths—\u003cb data-path-to-node=\"11,1,0\" data-index-in-node=\"60\"\u003e100 mg \/ 4 mL\u003c\/b\u003e and \u003cb data-path-to-node=\"11,1,0\" data-index-in-node=\"78\"\u003e400 mg \/ 16 mL\u003c\/b\u003e—equipping clinical staff to accurately calculate and prepare customized patient infusions.\u003c\/p\u003e\n\u003cp data-path-to-node=\"11,2,0\"\u003e\u003cb data-path-to-node=\"11,2,0\" data-index-in-node=\"0\"\u003eStandardized Strength:\u003c\/b\u003e Both vial sizes maintain a consistent base strength of 25 mg\/mL, simplifying clinical preparation and dilution protocols.\u003c\/p\u003e\n\u003cp data-path-to-node=\"11,3,0\"\u003e\u003cb data-path-to-node=\"11,3,0\" data-index-in-node=\"0\"\u003eContamination Prevention:\u003c\/b\u003e Packaged strictly as single-use vials to maintain absolute sterility and safeguard against cross-contamination in sensitive oncology wards.\u003c\/p\u003e\n\u003cp data-path-to-node=\"12\"\u003e\u003cb data-path-to-node=\"12\" data-index-in-node=\"0\"\u003eEssential Storage \u0026amp; Preparation Guidelines\u003c\/b\u003e\u003c\/p\u003e\n\u003cp data-path-to-node=\"12\"\u003eProtecting the integrity of this specialized medication is vital for its clinical efficacy. Store the vials strictly in a refrigerator between 2°C to 8°C. \u003cb data-path-to-node=\"12\" data-index-in-node=\"198\"\u003eDo not freeze.\u003c\/b\u003e Keep the vial in its outer carton to protect it from light until the exact moment of clinical preparation.\u003c\/p\u003e\n\u003cp data-path-to-node=\"13\"\u003e\u003ci data-path-to-node=\"13\" data-index-in-node=\"0\"\u003e\u003cstrong\u003eImportant Notice:\u003c\/strong\u003e Bevatas is a highly specialized prescription medication. Warning: To be sold by retail on the prescription of an Oncologist only. It must be prescribed, diluted for IV infusion, and administered strictly by a Registered Medical Practitioner in a clinical setting.\u003c\/i\u003e\u003c\/p\u003e","brand":"Intas Pharmaceuticals","offers":[{"title":"100 mg","offer_id":50187600462181,"sku":null,"price":4200.0,"currency_code":"INR","in_stock":true},{"title":"400 mg","offer_id":50187600494949,"sku":null,"price":9450.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0877\/4618\/3525\/files\/BEVATAS-100-INTAS-Bevacizumab-100-1.png?v=1772604782"},{"product_id":"capecitabine-tablets-ip-500mg-capetero-500-hetero","title":"Capecitabine Tablets IP 500mg | Capetero-500 - Hetero","description":"\u003cp data-path-to-node=\"7\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"7\"\u003eDependable Oral Oncology Care\u003c\/b\u003e\u003c\/p\u003e\n\u003cp data-path-to-node=\"7\"\u003eWhen addressing complex oncology needs, healthcare providers and patients require treatments that deliver highly precise, targeted, and reliable results without unnecessary clinical disruption. The \u003cb data-index-in-node=\"228\" data-path-to-node=\"7\"\u003eCapecitabine Tablets IP\u003c\/b\u003e (commercially recognized as Capetero-500) provide a potent, targeted oral chemotherapy option designed to support critical long-term treatment plans. Manufactured by Hetero Healthcare Limited under their specialized Oncology division, these film-coated tablets ensure the steady clinical performance necessary for individuals navigating advanced health challenges.\u003c\/p\u003e\n\u003cp data-path-to-node=\"8\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"8\"\u003eWhy Choose Capetero-500 for Clinical Management?\u003c\/b\u003e\u003c\/p\u003e\n\u003cp data-path-to-node=\"8\"\u003eManaging intensive oncology conditions traditionally requires frequent, invasive clinical visits for intravenous infusions. Instead of disrupting daily life with constant hospital trips, patients benefit immensely from Capetero-500’s oral formulation, which empowers them to maintain consistent, reliable treatment regimens from the comfort of their own homes. Hetero is a globally trusted pioneer in pharmaceutical manufacturing, providing the built-in trust, stringent quality control, and proven efficacy that oncologists, specialized clinics, and leading pharmacies demand.\u003c\/p\u003e\n\u003cp data-path-to-node=\"9\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"9\"\u003eKey Product Specifications \u0026amp; Clinical Benefits\u003c\/b\u003e\u003c\/p\u003e\n\u003cp data-path-to-node=\"10,0,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"10,0,0\"\u003eTargeted Active Ingredient:\u003c\/b\u003e Contains premium-grade Capecitabine IP (\u003cb data-index-in-node=\"68\" data-path-to-node=\"10,0,0\"\u003e500 mg\u003c\/b\u003e per tablet), a highly effective oral chemotherapy agent clinically designed to interfere with the growth of specific abnormal cells.\u003c\/p\u003e\n\u003cp data-path-to-node=\"10,1,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"10,1,0\"\u003ePatient-Friendly Formulation:\u003c\/b\u003e Designed as a smooth, film-coated tablet to mask bitter tastes and make daily oral administration significantly easier for patients to swallow and tolerate.\u003c\/p\u003e\n\u003cp data-path-to-node=\"10,2,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"10,2,0\"\u003eOptimized Packaging:\u003c\/b\u003e Conveniently packaged in a 1 x 10 blister pack configuration, ensuring individual doses remain completely hygienic and protected from environmental degradation until the exact moment of consumption.\u003c\/p\u003e\n\u003cp data-path-to-node=\"10,3,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"10,3,0\"\u003eStreamlined Care:\u003c\/b\u003e Oral administration significantly improves patient comfort and compliance during long-term therapy compared to injectable alternatives.\u003c\/p\u003e\n\u003cp data-path-to-node=\"11\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"11\"\u003eEssential Storage \u0026amp; Usage Guidelines\u003c\/b\u003e\u003c\/p\u003e\n\u003cp data-path-to-node=\"11\"\u003eProtecting the integrity of this specialized medication is vital for its clinical efficacy. Store the tablets at a temperature not exceeding 30°C, and protect them strictly from light and moisture.\u003c\/p\u003e\n\u003cp data-path-to-node=\"12\"\u003e\u003ci data-index-in-node=\"0\" data-path-to-node=\"12\"\u003e\u003cstrong\u003eImportant Notice:\u003c\/strong\u003e Capetero-500 is a Schedule H Prescription Drug. Caution: Not to be sold by retail without the prescription of a Registered Medical Practitioner. Keep all medicines safely out of the reach of children.\u003c\/i\u003e\u003c\/p\u003e","brand":"Hetero Healthcare","offers":[{"title":"Default Title","offer_id":50187607048549,"sku":null,"price":499.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0877\/4618\/3525\/files\/CAPETERO-500-HETERO-Capecitabine-_500mg_-1.png?v=1772605549"},{"product_id":"letrozole-tablets-ip-2-5mg-letero-hetero-oncology","title":"Letrozole Tablets IP 2.5mg | Letero - Hetero Oncology","description":"\u003cp data-path-to-node=\"7\"\u003e\u003cb data-path-to-node=\"7\" data-index-in-node=\"0\"\u003eAdvanced Targeted Oncology \u0026amp; Hormone Therapy\u003c\/b\u003e\u003c\/p\u003e\n\u003cp data-path-to-node=\"7\"\u003eWhen addressing specific hormone-receptor-positive oncology conditions, healthcare providers and patients require treatments that deliver highly precise, targeted, and reliable results. The \u003cb data-path-to-node=\"7\" data-index-in-node=\"235\"\u003eLetrozole Tablets IP\u003c\/b\u003e (commercially recognized as Letero) provide a potent, targeted oral therapy designed to lower estrogen levels and support critical long-term treatment plans. Manufactured by Hetero Healthcare Limited under their specialized Oncology division, these film-coated tablets ensure the steady clinical performance necessary for individuals navigating advanced health challenges.\u003c\/p\u003e\n\u003cp data-path-to-node=\"8\"\u003e\u003cb data-path-to-node=\"8\" data-index-in-node=\"0\"\u003eWhy Choose Letero for Clinical Management?\u003c\/b\u003e\u003c\/p\u003e\n\u003cp data-path-to-node=\"8\"\u003eManaging intensive oncology conditions requires strict daily protocol adherence. Letero is an aromatase inhibitor that offers a highly effective oral formulation, empowering patients to maintain consistent, reliable treatment regimens from the comfort of their own homes without relying solely on invasive clinical visits. Hetero is a globally trusted pioneer in pharmaceutical manufacturing, providing the built-in trust, stringent quality control, and proven efficacy that oncologists, cancer institutions, and specialized pharmacies demand.\u003c\/p\u003e\n\u003cp data-path-to-node=\"9\"\u003e\u003cb data-path-to-node=\"9\" data-index-in-node=\"0\"\u003eKey Product Specifications \u0026amp; Clinical Benefits\u003c\/b\u003e\u003c\/p\u003e\n\u003cp data-path-to-node=\"10,0,0\"\u003e\u003cb data-path-to-node=\"10,0,0\" data-index-in-node=\"0\"\u003eTargeted Active Ingredient:\u003c\/b\u003e Contains premium-grade Letrozole IP (\u003cb data-path-to-node=\"10,0,0\" data-index-in-node=\"65\"\u003e2.5 mg\u003c\/b\u003e per tablet), a highly effective oral anti-estrogen therapy clinically designed to inhibit the aromatase enzyme.\u003c\/p\u003e\n\u003cp data-path-to-node=\"10,1,0\"\u003e\u003cb data-path-to-node=\"10,1,0\" data-index-in-node=\"0\"\u003ePatient-Friendly Formulation:\u003c\/b\u003e Designed as a smooth, film-coated yellow tablet to mask bitter tastes and make daily oral administration significantly easier for patients to swallow and tolerate.\u003c\/p\u003e\n\u003cp data-path-to-node=\"10,2,0\"\u003e\u003cb data-path-to-node=\"10,2,0\" data-index-in-node=\"0\"\u003eOptimized Packaging:\u003c\/b\u003e Conveniently packaged in a 10-tablet blister pack configuration, ensuring individual doses remain completely hygienic and protected from environmental degradation until the exact moment of consumption.\u003c\/p\u003e\n\u003cp data-path-to-node=\"10,3,0\"\u003e\u003cb data-path-to-node=\"10,3,0\" data-index-in-node=\"0\"\u003eStreamlined Care:\u003c\/b\u003e Oral administration significantly improves patient comfort and compliance during long-term maintenance therapy.\u003c\/p\u003e\n\u003cp data-path-to-node=\"11\"\u003e\u003cb data-path-to-node=\"11\" data-index-in-node=\"0\"\u003eEssential Storage \u0026amp; Usage Guidelines\u003c\/b\u003e\u003c\/p\u003e\n\u003cp data-path-to-node=\"11\"\u003eProtecting the integrity of this specialized medication is vital for its clinical efficacy. Store the tablets at a temperature not exceeding 30°C, and protect them strictly from light and moisture.\u003c\/p\u003e\n\u003cp data-path-to-node=\"12\"\u003e\u003ci data-path-to-node=\"12\" data-index-in-node=\"0\"\u003e\u003cstrong\u003eImportant Notice:\u003c\/strong\u003e Letero is a Schedule H Prescription Drug. Caution: It is dangerous to take this preparation except under medical supervision. Warning: To be sold against demand from Hospitals \/ Cancer Institutions for their use and against the prescription of a Registered Medical Practitioner \/ Cancer Specialists only. Keep safely out of the reach of children.\u003c\/i\u003e\u003c\/p\u003e","brand":"Hetero Healthcare","offers":[{"title":"Default Title","offer_id":50187638669669,"sku":null,"price":52.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0877\/4618\/3525\/files\/LETERO-2.5-HETERO-Letrozole-2.5-mg-1.png?v=1772612893"}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0877\/4618\/3525\/collections\/VA-Category-card-onclogy.png?v=1774276191","url":"https:\/\/vishalagency.com\/collections\/oncology.oembed","provider":"Vishal Agencies","version":"1.0","type":"link"}